+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coronary Artery Disease Treatment Devices Market - Global Forecast 2026-2032- Product Image
Coronary Artery Disease Treatment Devices Market - Global Forecast 2026-2032- Product Image
Sale

Coronary Artery Disease Treatment Devices Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989780
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coronary Artery Disease Treatment Devices Market is projected to reach USD 5.13 Billion in 2026. It is expected to continue growing at a CAGR of 5.94%, reaching USD 7.26 Billion by 2032.

Coronary artery disease treatment devices are central to modern cardiovascular care, spanning drug-eluting stents, bare-metal stents, balloon catheters, atherectomy systems, thrombectomy devices, intravascular imaging platforms, pressure guidewires, embolic protection devices, and adjunctive technologies used in percutaneous coronary intervention and surgical revascularization.

Demand is anchored by the global burden of ischemic heart disease, which remains the world’s leading cause of death according to the World Health Organization. Aging populations, diabetes, obesity, hypertension, tobacco exposure, and improved access to catheterization laboratories continue to sustain procedural volumes, while clinical guidelines increasingly emphasize evidence-based lesion assessment, optimal medical therapy, and patient-specific revascularization strategies.

Transformative Shifts in the Coronary Device Landscape

The coronary artery disease treatment devices landscape is shifting from purely mechanical vessel opening toward precision revascularization. New-generation drug-eluting stents with thinner struts, biocompatible polymers, and improved deliverability have reduced restenosis and stent thrombosis compared with earlier platforms, while drug-coated balloons are expanding options for in-stent restenosis and small-vessel disease in selected patients.

Hospitals and cardiology networks are also adopting intravascular ultrasound, optical coherence tomography, and fractional flow reserve or non-hyperemic pressure ratio tools to improve lesion selection and stent optimization. At the same time, value-based purchasing, same-day discharge pathways after PCI, and growing use of radial access are reshaping procurement priorities toward safety, workflow efficiency, and total cost of care.

Cumulative Impact of Artificial Intelligence on CAD Devices

Artificial intelligence is becoming a cumulative force across coronary artery disease treatment, beginning with risk stratification and extending into imaging, cath lab planning, procedural support, and post-procedure monitoring. AI-enabled analysis of coronary CT angiography, angiograms, IVUS, and OCT can help quantify plaque burden, identify high-risk anatomy, and support more consistent interpretation across operators.

In device markets, AI is also improving operational performance through predictive maintenance, inventory optimization, clinical trial enrichment, and real-world evidence generation. The strongest near-term impact is expected where AI augments clinician decision-making without replacing established guideline-based practice, particularly in lesion assessment, stent sizing, restenosis prediction, and longitudinal follow-up of high-risk patients.

Key Regional Insights for CAD Treatment Devices

Asia-Pacific is a high-growth region for coronary artery disease treatment devices due to large patient pools, rapid hospital infrastructure expansion, and rising adoption of PCI in China, India, Japan, South Korea, and Australia. North America remains a technology leadership hub, supported by advanced cath lab capacity, structured reimbursement, FDA-regulated innovation pathways, and high use of intravascular imaging and physiology-guided intervention.

Europe benefits from mature cardiovascular care networks and guideline-driven adoption of drug-eluting stents, drug-coated balloons, and imaging-guided PCI, with Germany, France, Italy, Spain, and the United Kingdom shaping procedural standards. Latin America is expanding access through private hospital investment and public procurement, led by Brazil and Mexico. The Middle East is investing in tertiary cardiac centers, particularly in GCC markets with high cardiometabolic risk, while Africa shows long-term potential as catheterization infrastructure, specialist training, and device availability improve.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gaining importance as Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and Singapore improve access to interventional cardiology, cardiovascular screening, and tertiary hospital services. The GCC is characterized by high cardiometabolic risk, strong hospital investment, and preference for premium cardiovascular technologies in major urban centers, reinforcing demand for advanced stents, imaging systems, and complex PCI support devices.

The European Union supports device adoption through harmonized regulatory oversight under the Medical Device Regulation, although clinical evidence and post-market surveillance requirements have increased market entry complexity. BRICS countries combine large ischemic heart disease burden with expanding domestic manufacturing, procurement localization, and broader cath lab capacity. G7 nations remain key innovation, reimbursement, and clinical evidence markets, while NATO-aligned healthcare systems are creating demand for resilient medical supply chains, cybersecurity-ready digital platforms, and diversified sourcing for critical cardiovascular devices.

Key Country Insights for Coronary Artery Disease Treatment Devices

The United States leads in high-value coronary device utilization, supported by large PCI volumes, advanced imaging use, radial access adoption, and active clinical research. Canada emphasizes quality outcomes and public reimbursement discipline, while Mexico and Brazil are expanding interventional access through mixed public-private systems and growing tertiary care capacity. The United Kingdom, Germany, France, Italy, and Spain continue to influence European practice through guideline implementation, national procurement, structured registries, and strong cardiology societies.

Russia maintains demand through centralized hospital networks but faces procurement and supply-chain complexity. China is scaling domestic stent and catheter production while expanding advanced PCI capacity and hospital access. India combines high disease burden with price-sensitive procurement and rapid cath lab growth. Japan and South Korea are advanced technology adopters with strong operator expertise, high procedural quality expectations, and established use of intravascular imaging, while Australia maintains a mature, outcomes-focused cardiovascular device environment supported by evidence-based reimbursement and specialist cardiac networks.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical evidence, including randomized trials, registry data, and real-world outcomes for complex PCI, diabetes, small-vessel disease, calcified lesions, bifurcation lesions, and high bleeding-risk patients. Evidence generation should be paired with health-economic models that demonstrate reductions in repeat revascularization, hospital stay, complications, and long-term care costs.

Manufacturers should invest in AI-enabled imaging partnerships, physician training, supply-chain resilience, cybersecurity readiness, and region-specific pricing strategies. Winning portfolios will integrate stents, balloons, atherectomy, thrombectomy, imaging, physiology, and digital workflow tools into procedure-ready solutions that help hospitals improve outcomes while managing reimbursement pressure and procurement scrutiny.

Research Methodology for Market and Clinical Insights

This executive summary is based on triangulation of verified secondary research, clinical guideline review, regulatory intelligence, public health data, peer-reviewed literature, epidemiology databases, and procedure trend analysis. Core references include global cardiovascular disease data from public health authorities, cardiology society recommendations, medical device regulatory frameworks, and published evidence on PCI technologies.

The methodology emphasizes cross-validation across disease burden, technology adoption, reimbursement conditions, regulatory requirements, and regional healthcare capacity. Insights were structured to support strategic planning for coronary artery disease treatment device manufacturers, distributors, investors, hospital procurement teams, and innovation partners operating across developed and emerging cardiovascular markets.

Conclusion: Strategic Outlook for CAD Treatment Devices

The coronary artery disease treatment devices landscape is advancing toward precision, evidence-based, and digitally supported revascularization. Momentum is supported by persistent ischemic heart disease burden, rising procedural access, and continuous innovation across stents, balloons, atherectomy, thrombectomy, imaging, and physiology-guided tools.

Future leadership will depend on clinical differentiation, affordability, regulatory readiness, supply-chain resilience, and integration with AI-enabled decision support. Organizations that align innovation with measurable patient outcomes, cath lab efficiency, and regional access needs will be best positioned to compete in the evolving global CAD treatment ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Coronary Artery Disease Treatment Devices Market, by Device Type
7.1. Introduction
7.2. Atherectomy Device
7.2.1. Laser Atherectomy
7.2.2. Orbital Atherectomy
7.2.3. Rotational Atherectomy
7.3. Balloon Catheter
7.3.1. Cutting Balloon Catheter
7.3.2. Drug-Coated Balloon Catheter
7.3.3. Standard Balloon Catheter
7.4. Intravascular Imaging System
7.4.1. Fractional Flow Reserve
7.4.2. Intravascular Ultrasound
7.4.3. Optical Coherence Tomography
7.5. Stent Systems
7.5.1. Bare Metal Stent
7.5.2. Drug Eluting Stent
8. Coronary Artery Disease Treatment Devices Market, by Material Composition
8.1. Introduction
8.2. Metals
8.2.1. Stainless Steel
8.2.2. Cobalt-Chromium
8.2.3. Platinum-Chromium
8.3. Polymers
8.4. Bioabsorbable
8.4.1. Magnesium Alloys
8.4.2. Poly-L-lactic Acid
9. Coronary Artery Disease Treatment Devices Market, by Treatment Type
9.1. Introduction
9.2. Coronary Artery Bypass Grafting
9.2.1. Off Pump
9.2.2. On Pump
9.3. Percutaneous Coronary Intervention
10. Coronary Artery Disease Treatment Devices Market, by Approach
10.1. Introduction
10.2. Transfemoral Approach
10.3. Transradial Approach
11. Coronary Artery Disease Treatment Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cardiac Centers
11.4. Hospitals & Clinics
12. Coronary Artery Disease Treatment Devices Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Coronary Artery Disease Treatment Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Coronary Artery Disease Treatment Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Abiomed, Inc.
16.3. AngioDynamics, Inc.
16.4. B. Braun Melsungen AG
16.5. Becton, Dickinson and Company
16.6. Biosensors International Group, Ltd.
16.7. Biotronik SE & Co. KG
16.8. Boston Scientific Corporation
16.9. Cardinal Health, Inc.
16.10. Cook Medical Inc.
16.11. Edwards Lifesciences Corporation
16.12. Johnson & Johnson Services Inc.
16.13. Koninklijke Philips N.V.
16.14. Lepu Medical Technology (Beijing) Co., Ltd.
16.15. Medtronic plc
16.16. Meril Life Sciences Pvt. Ltd.
16.17. Merit Medical Systems, Inc.
16.18. MicroPort Scientific Corporation
16.19. Penumbra, Inc.
16.20. Shockwave Medical, Inc.
16.21. Teleflex Incorporated
16.22. Terumo Corporation
16.23. W. L. Gore & Associates, Inc.
16.24. Zylox-Tonbridge Medical Technology Co., Ltd.
List of Figures
FIGURE 1. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ATHERECTOMY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ATHERECTOMY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ATHERECTOMY DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL LASER ATHERECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL LASER ATHERECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL LASER ATHERECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ORBITAL ATHERECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ORBITAL ATHERECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ORBITAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BALLOON CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BALLOON CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CUTTING BALLOON CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CUTTING BALLOON CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CUTTING BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG-COATED BALLOON CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG-COATED BALLOON CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG-COATED BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL STANDARD BALLOON CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL STANDARD BALLOON CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL STANDARD BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL INTRAVASCULAR IMAGING SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL INTRAVASCULAR IMAGING SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL INTRAVASCULAR IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL OPTICAL COHERENCE TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL OPTICAL COHERENCE TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL OPTICAL COHERENCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL STENT SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL STENT SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL STENT SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BARE METAL STENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BARE METAL STENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BARE METAL STENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL METALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL METALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL METALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL COBALT-CHROMIUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL COBALT-CHROMIUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL COBALT-CHROMIUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PLATINUM-CHROMIUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PLATINUM-CHROMIUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PLATINUM-CHROMIUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL BIOABSORBABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL BIOABSORBABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL BIOABSORBABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MAGNESIUM ALLOYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL MAGNESIUM ALLOYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL MAGNESIUM ALLOYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL POLY-L-LACTIC ACID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL POLY-L-LACTIC ACID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL POLY-L-LACTIC ACID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL OFF PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL OFF PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL OFF PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ON PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ON PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ON PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL TRANSFEMORAL APPROACH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL TRANSFEMORAL APPROACH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL TRANSFEMORAL APPROACH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL TRANSRADIAL APPROACH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL TRANSRADIAL APPROACH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL TRANSRADIAL APPROACH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CARDIAC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CARDIAC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 146. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 147. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 148. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 149. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 150. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 151. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 152. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 153. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 154. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 155. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 156. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 159. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 160. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 172. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 173. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 174. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 175. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 176. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 177. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 178. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 179. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 180. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 181. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 182. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 186. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 187. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 188. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 189. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 190. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 191. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 192. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 193. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 194. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 195. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 196. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 198. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 199. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 200. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 201. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 202. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 203. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 204. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 205. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 206. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 207. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 208. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 209. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 225. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 226. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 227. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 228. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 229. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 230. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 231. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 232. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 233. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 234. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 235. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 238. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 239. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 240. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 241. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 242. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 243. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 244. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 245. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 246. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 247. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 248. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 249. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 250. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 251. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 252. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 253. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 254. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 255. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 256. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 257. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 258. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 259. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 260. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 261. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 272. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 273. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 274. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 277. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 278. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 279. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 280. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 281. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 282. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 283. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 284. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 285. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 286. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 287. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 288. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 291. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 292. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2017-2032 (USD MILLION)
TABLE 293. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2017-2032 (USD MILLION)
TABLE 294. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 295. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2017-2032 (USD MILLION)
TABLE 296. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 297. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2017-2032 (USD MILLION)
TABLE 298. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 299. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2017-2032 (USD MILLION)
TABLE 300. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2017-2032 (USD MILLION)
TABLE 301. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER,

Companies Mentioned

  • Abbott Laboratories
  • Abiomed, Inc.
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical Inc.
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • Zylox-Tonbridge Medical Technology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.13 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.26 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Atherectomy Devices Market - Global Forecast 2026-2032 - Product Image

Atherectomy Devices Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Revascularization Device Market - Global Forecast 2026-2032 - Product Image

Revascularization Device Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Atherectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Atherectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Interventional Cardiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Interventional Cardiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Percutaneous Coronary Intervention (PCI) Devices - Global Strategic Business Report - Product Image

Percutaneous Coronary Intervention (PCI) Devices - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.